BioSig Technologies Inc.

0.5809-0.0133-2.24%Vol 102.48K1Y Perf -82.26%
Aug 5th, 2022 15:59 DELAYED
BID0.5700 ASK0.5985
Open0.6000 Previous Close0.5942
Pre-Market- After-Market0.60
 - -  0.02 3.03%
Target Price
4.00 
Analyst Rating
Strong Buy 1.00
Potential %
588.59 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★+     42.15
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
2.25 
Earnings Rating
Neutral
Market Cap25.53M 
Earnings Date
10th Aug 2022
Alpha-0.02 Standard Deviation0.21
Beta1.79 

Today's Price Range

0.57000.6002

52W Range

0.50004.10

5 Year PE Ratio Range

-3.20-3.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.33%
1 Month
-15.37%
3 Months
-28.28%
6 Months
-64.58%
1 Year
-82.26%
3 Years
-91.13%
5 Years
-84.00%
10 Years
-

TickerPriceChg.Chg.%
BSGM0.5809-0.0133-2.24
AAPL165.35-0.2300-0.14
GOOG118.22-0.6500-0.55
MSFT282.91-0.7400-0.26
XOM88.451.26001.45
WFC43.760.99002.31
JNJ171.11-0.6800-0.40
FB196.640.99000.51
GE74.360.69000.94
JPM115.763.40003.03
 
ProfitabilityValueIndustryS&P 500US Markets
69.80
-9 944.40
-9 880.70
-
-
RevenueValueIndustryS&P 500US Markets
124.00K
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.38-
Q02 2020--0.72-
Q01 2020-0.25-0.46-84.00
Q03 2019--0.25-
Q02 2019--0.38-
Q01 2018--0.22-
Q02 2017--0.30-
Q01 2017--0.35-
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.17-13.33Negative
9/2022 QR-0.14-7.69Negative
12/2022 FY-0.66-13.79Negative
12/2023 FY-0.38-2.70Negative
Next Report Date10th Aug 2022
Estimated EPS Next Report-0.17
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume102.48K
Shares Outstanding43.95K
Shares Float39.49M
Trades Count386
Dollar Volume59.78K
Avg. Volume188.84K
Avg. Weekly Volume106.81K
Avg. Monthly Volume159.28K
Avg. Quarterly Volume300.42K

BioSig Technologies Inc. (NASDAQ: BSGM) stock closed at 0.5809 per share at the end of the most recent trading day (a -2.24% change compared to the prior day closing price) with a volume of 102.48K shares and market capitalization of 25.53M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 53 people. BioSig Technologies Inc. CEO is Kenneth L. Londoner.

The one-year performance of BioSig Technologies Inc. stock is -82.26%, while year-to-date (YTD) performance is -73.95%. BSGM stock has a five-year performance of -84%. Its 52-week range is between 0.5 and 4.1007, which gives BSGM stock a 52-week price range ratio of 2.25%

BioSig Technologies Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 2.98, a price-to-sale (PS) ratio of 214.52, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -170.33%, a ROC of -209.03% and a ROE of -215.65%. The company’s profit margin is -%, its EBITDA margin is -9 880.70%, and its revenue ttm is $124.00 Thousand , which makes it $0.00 revenue per share.

Of the last four earnings reports from BioSig Technologies Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. BioSig Technologies Inc.’s next earnings report date is 10th Aug 2022.

The consensus rating of Wall Street analysts for BioSig Technologies Inc. is Strong Buy (1), with a target price of $4, which is +588.59% compared to the current price. The earnings rating for BioSig Technologies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioSig Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioSig Technologies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.12, ATR14 : 0.08, CCI20 : -58.06, Chaikin Money Flow : -0.04, MACD : -0.04, Money Flow Index : 58.34, ROC : -4.09, RSI : 25.40, STOCH (14,3) : 49.63, STOCH RSI : 0.39, UO : 48.92, Williams %R : -50.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioSig Technologies Inc. in the last 12-months were: Kenneth L. Londoner (Buy at a value of $289 768)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

BioSig Technologies Inc.

BioSig Technologies Inc is a medical technology company. The firm is commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. Its first product, PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The company's subsidiary is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.

CEO: Kenneth L. Londoner

Telephone: +1 203 409-5444

Address: 54 Wilton Road, Westport 06880, CT, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

57%43%

Bearish Bullish

52%48%

TipRanks News for BSGM


News

Stocktwits